Both in Pharmaceuticals
Mannatech vs Neuphoria Therapeutics
Over the past year MTEX returned −4.2% and NEUP returned −28.7%; their daily moves had a correlation of 0.15.
MTEX −4.2% NEUP −28.7%Growth of $1, one year, split-adjusted
| Metric | MTEX | NEUP |
|---|---|---|
| Price | $8.52 | $3.36 |
| Market cap | $16.4M | $18.2M |
| Today | +1.67% | −0.89% |
| 1 month | +12.1% | −5.9% |
| 6 months | +91.0% | −35.3% |
| Year to date | +3.3% | −13.4% |
| 1 year | — | −25.8% |
| Revenue growth (YoY) | +3.8% | — |
| Gross margin | 76.9% | — |
| Net margin | 3.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | — |
| Net cash | $2.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 100.6% | 21.4% |
| Short % of float | 1.8% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).